PIM
VNDA icon

Profit Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Profit Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-186,400
Closed -$930K – 63
2025
Q3 		$930K Sell
186,400
-143,422
-43% -$664K 1.17% 40
2025
Q2 		$1.56M Hold
329,822
– – 1.4% 29
2025
Q1 		$1.51M Hold
329,822
– – 1.41% 31
2024
Q4 		$1.58M Hold
329,822
– – 1.27% 36
2024
Q3 		$1.55M Sell
329,822
-241,502
-42% -$1.29M 1.22% 38
2024
Q2 		$3.23M Buy
571,324
+351,000
+159% +$1.81M 2.02% 22
2024
Q1 		$906K Sell
220,324
-168,950
-43% -$676K 0.51% 55
2023
Q4 		$1.64M Buy
389,274
+62,277
+19% +$251K 0.94% 38
2023
Q3 		$1.41M Sell
326,997
-1,671
-0.5% -$9.28K 1% 37
2023
Q2 		$2.17M Sell
328,668
-4,195
-1% -$26.9K 1.41% 27
2023
Q1 		$2.26M Sell
332,863
-2,091
-0.6% -$14.7K 1.49% 25
2022
Q4 		$2.48M Hold
334,954
– – 1.74% 24
2022
Q3 		$3.31M Buy
334,954
+53,064
+19% +$560K 2.53% 15
2022
Q2 		$3.07M Hold
281,890
– – 2.26% 20
2022
Q1 		$3.19M Buy
281,890
+43,830
+18% +$576K 1.97% 24
2021
Q4 		$3.73M Buy
238,060
+159,906
+205% +$2.79M 2.35% 17
2021
Q3 		$1.34M Sell
78,154
-178,392
-70% -$3.12M 0.93% 31
2021
Q2 		$5.52M Hold
256,546
– – 2.92% 9
2021
Q1 		$3.85M Sell
256,546
-5,345
-2% -$86.5K 2.19% 17
2020
Q4 		$3.44M Hold
261,891
– – 2.21% 18
2020
Q3 		$2.53M Buy
261,891
+70,901
+37% +$758K 1.56% 24
2020
Q2 		$2.19M Buy
190,990
+85,756
+81% +$971K 1.53% 26
2020
Q1 		$1.09M Buy
+105,234
New +$1.3M 1.02% 46

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Profit Investment Management's VNDA Position: Q4 2025 in Review

Profit Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2025, closing a stake of 186,400 shares — an estimated $930K sold.

Profit Investment Management first reported a position in VNDA in Q1 2020 and held it in 23 quarters. The position peaked at $5.52M in Q2 2021. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

  • Profit Investment Management reported no remaining Vanda Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Profit Investment Management sold 186,400 Vanda Pharmaceuticals shares in Q4 2025, an estimated $930K.
  • Profit Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2020 and held it in 23 quarters.
  • Profit Investment Management's Vanda Pharmaceuticals position peaked at $5.52M in Q2 2021.
  • 153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Profit Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.